Published in Leukemia on September 24, 2009
Pushing the limits of targeted therapy in chronic myeloid leukaemia. Nat Rev Cancer (2012) 2.35
Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood (2011) 1.68
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. Oncotarget (2011) 1.27
Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model. PLoS One (2011) 1.02
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One (2013) 0.98
Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy. World J Stem Cells (2012) 0.76
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia. PLoS One (2017) 0.75
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J (2001) 3.88
Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol (1987) 3.84
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia (2009) 2.94
A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91
Homing receptors and the control of lymphocyte migration. Immunol Rev (1986) 2.26
Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia (2007) 2.11
A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science (1992) 2.06
Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.80
Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circ Res (2000) 1.61
Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med (1998) 1.61
Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med (1993) 1.58
Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. J Cell Biol (1988) 1.51
Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study. Crit Care Med (2000) 1.49
Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med (1995) 1.48
Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol (1997) 1.46
How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol (1997) 1.43
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol (1999) 1.42
VAP-1: an adhesin and an enzyme. Trends Immunol (2001) 1.41
CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73. J Exp Med (1995) 1.37
Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment. Lancet (1992) 1.37
Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology (1994) 1.37
Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol (1993) 1.35
Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol (1993) 1.34
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet (2000) 1.27
A cell surface amine oxidase directly controls lymphocyte migration. Immunity (2001) 1.24
Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes (1996) 1.23
Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans. Gastroenterology (2001) 1.22
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol (1998) 1.20
Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc Natl Acad Sci U S A (1997) 1.20
CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. J Immunol (2000) 1.19
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med (1997) 1.18
Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med (2001) 1.17
Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med (1996) 1.17
Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol (1998) 1.13
Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J (2001) 1.13
Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol (1992) 1.11
Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. Leukemia (2011) 1.11
Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol (2001) 1.05
Human lymphocyte and lymphoma homing receptors. Annu Rev Med (1987) 1.05
Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol (2000) 1.05
Molecules controlling lymphocyte migration to the gut. Gut (1999) 1.04
Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology (2000) 1.04
Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol (1999) 1.04
Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest (1997) 1.04
Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology (1996) 1.03
Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J Med Genet (2004) 1.03
In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol (2000) 1.03
Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J Immunol (1993) 1.02
Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur J Immunol (1995) 1.02
Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J (2001) 1.00
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia (2013) 1.00
YadA mediates specific binding of enteropathogenic Yersinia enterocolitica to human intestinal submucosa. Infect Immun (1994) 0.98
Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). Eur J Immunol (1996) 0.98
Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients. Leukemia (2011) 0.97
CD73 mediates adhesion of B cells to follicular dendritic cells. Blood (1996) 0.97
Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol (1998) 0.96
Cell adhesion and migration. IV. Lymphocyte trafficking in the intestine and liver. Am J Physiol (1998) 0.95
Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A (1992) 0.95
Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun (1993) 0.94
Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues. Gastroenterol Clin North Am (1991) 0.94
Immunological detection of proteins after isoelectric focusing in thin layer agarose gel: a specific application for the characterization of immunoglobulin diversity. J Clin Lab Immunol (1983) 0.94
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia (2012) 0.93
Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets. Blood (1989) 0.93
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation. Blood Cancer J (2013) 0.93
Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer (1993) 0.92
Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm Bowel Dis (1998) 0.92
Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect Immun (1997) 0.92
Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng (1998) 0.92
Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. Am J Pathol (1999) 0.91
Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet (2001) 0.91
Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion. Leukemia (2012) 0.90
Serum CD44 in malignant lymphoma: an association with treatment response. Blood (1994) 0.90
Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Blood (1997) 0.89
Defect in the generation of light-chain diversity in bursectomized chickens. Nature (1984) 0.89
Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis Rheum (1998) 0.89
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J Med Genet (2006) 0.89
Endothelial cell-binding properties of lymphocytes infiltrated into human diabetic pancreas. Implications for pathogenesis of IDDM. Diabetes (1993) 0.88
CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol (1995) 0.88
Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur J Immunol (1997) 0.88
The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes. J Immunol (1998) 0.86
Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer (1990) 0.86
Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. Blood (1996) 0.85
Interactions between endothelial cells and leukocytes. J Cell Biochem (1986) 0.85
Origin and function of circulating CD44 in non-Hodgkin's lymphoma. J Immunol (1997) 0.85
Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation (1999) 0.85
Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res (1997) 0.84
Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. J Immunol (2001) 0.84
Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats. Am J Pathol (2000) 0.83
Serum lipids and lipoproteins in children, adolescents and young adults in 1980-1986. Ann Med (1991) 0.83
CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. Eur J Immunol (1997) 0.83